Surgical Site Infection Clinical Trial
Official title:
A Randomized Controlled Trial of Bowel-Prepped vs Non-Bowel-Prepped Laparoscopic Colorectal Surgery
Research Question: Are anastomotic leak and surgical site infection rates equivalent in
patients having laparoscopic bowel resections without bowel preparation vs those having
bowel preparation?
Bowel preparation is a distressing and uncomfortable procedure for patients undergoing
laparoscopic colorectal surgery, and also carries some risk of morbidity due to dehydration,
electrolyte inbalance and possible infectious complications. If it is found that there is no
difference between those patients who have preoperative bowel preps and those who do not
have them, then we can save these patients this additional distress and risk at the time of
their surgery.
Rationale: The question of whether a bowel prep is needed for colon resection in open
surgery has been answered. However, in laparoscopic colorectal resections, it has not been
prospectively investigated. Usually, reasons for still using a bowel prep in laparoscopic
colon resections is that small instruments grasping the colon can tear it, and without a
prep, stool spillage can result. As well, it may be difficult to manipulate a colon filled
with stool, and difficult to identify lesions to be resected.
There are no previous randomized trials in the laparoscopic literature comparing
laparoscopic colorectal resections with and without bowel preparations. There are a number
of trials for open resections and one trial including both laparoscopic and open resections.
Unfortunately this trial does not separate the data analysis for these two groups.
Primary and Secondary Outcomes: The question to be identified is whether anastomotic leaks,
and surgical site infection rates are equivalent in patients having laparoscopic resections
without bowel prep versus prepped patients.
Methodology: Once consent is obtained, the patients will be randomized into two groups-the
study group who will eat a low residue diet prior to surgery and who will not undergo bowel
preparation, or the control group who will complete the standard bowel preparation protocol.
Both groups will have the scheduled surgery. All patients will be monitored for signs of
anastomotic leak and surgical wound infection daily while in hospital and at routine follow
up visits at 2 and 6 weeks postoperative. If these two complications are observed, standard
treatment will be followed.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04096885 -
The Inselspital Surgical Cohort Study
|
||
Terminated |
NCT03820648 -
Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Terminated |
NCT04042077 -
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
|
Phase 3 | |
Completed |
NCT05841576 -
Anaesthetic Management Guided by COMET Measurements
|
N/A | |
Withdrawn |
NCT05338281 -
NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT01697748 -
Prospective Study on Cesarean Wound Outcomes
|
N/A | |
Terminated |
NCT01789697 -
Text Message Study
|
N/A | |
Recruiting |
NCT05966961 -
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
|
||
Recruiting |
NCT05077592 -
Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections
|
Phase 4 | |
Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
Recruiting |
NCT05763602 -
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
|
Phase 4 | |
Recruiting |
NCT03221023 -
Intrawound Vancomycin Prophylaxis for Neural Stimulator
|
Phase 2/Phase 3 | |
Completed |
NCT03257202 -
Topical Treatment and Prevalence of P. Acnes
|
Phase 2 | |
Completed |
NCT06154720 -
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
|
||
Not yet recruiting |
NCT06465901 -
A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI
|
N/A | |
Not yet recruiting |
NCT04820075 -
Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Not yet recruiting |
NCT04496180 -
Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
|
N/A |